AI and Computational Analysis at the Molecular Targets and Cancer Therapeutics Symposium

October 27, 2022 11:00am - 12:30pm Hybrid: Virtual/In-Person Cancer Data Science Initiatives

Eric Stahlberg, Ph.D., will co-chair a workshop on AI and Computational Analysis at the Molecular Targets and Cancer Therapeutics Symposium in Barcelona, Spain, on October 27, 2022. The Symposium is jointly sponsored by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI), and the American Association for Cancer Research (AACR). Workshop presenters:

  • Eytan Ruppin, National Cancer Institute, USA
  • Nuria Lopes-Bigas, Institute for Research in Biomedicine, Barcelona, Spain
  • Emiliano Calvo, START Madrid, Spain
  • Pedro Cutillas, Co-chair, Barts Cancer Institute, United Kingdom
  • Eric Stahlberg, Co-chair, Frederick National Laboratory for Cancer Research, USA

At the workshop, Stahlberg will highlight the work of the Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium, the public-private partnership with a mission to transform drug discovery by accelerating the development of more effective therapies for patients.

Registration is available for in-person or virtual participation for the Symposium.

The workshop starts at 5 p.m. CEST. Session code: 130.

2022-10-27 11:00 2022-10-27 12:30 America/New_York AI and Computational Analysis at the Molecular Targets and Cancer Therapeutics Symposium

Eric Stahlberg, Ph.D., will co-chair a workshop on AI and Computational Analysis at the Molecular Targets and Cancer Therapeutics Symposium in Barcelona, Spain, on October 27, 2022. The Symposium is jointly sponsored by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI), and the American Association for Cancer Research (AACR). Workshop presenters:

  • Eytan Ruppin, National Cancer Institute, USA
  • Nuria Lopes-Bigas, Institute for Research in Biomedicine, Barcelona, Spain
  • Emiliano Calvo, START Madrid, Spain
  • Pedro Cutillas, Co-chair, Barts Cancer Institute, United Kingdom
  • Eric Stahlberg, Co-chair, Frederick National Laboratory for Cancer Research, USA

At the workshop, Stahlberg will highlight the work of the Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium, the public-private partnership with a mission to transform drug discovery by accelerating the development of more effective therapies for patients.

Registration is available for in-person or virtual participation for the Symposium.

The workshop starts at 5 p.m. CEST. Session code: 130.



Register
Hybrid: Virtual/In-Person Frederick National Laboratory